i_need_contribute
The National Institutes of Health COVID-19 Treatment Guidelines Panel hasadded a recommendation to prescribe dexamethasone for COVID-19 patients who are mechanically ventilated or require supplemental oxygen. Citing the RECOVERY trial for hospitalized patients in the United Kingdom, the panel advises using the drug at a dose of 6 mg per day for up to 10 days, with a strong recommendation for patients who are mechanically ventilated and a moderate recommendation for patients who require supplemental oxygen but are not mechanically ventilated. The panel says that the drug shouldn't be offered to COVID-19 patients who do not require supplemental oxygen.
The Infectious Diseases Society of America also added dexamethasone recommendations to its treatment guidelines for COVID-19 patients this week.
Officials from the Centers for Disease Control and Prevention (CDC) estimate that more than 20 million Americans may have been infected with SARS-CoV-2, Reuters reports, while only one tenth of those cases have been recorded. They based this estimate on serology testing, which identified SARS-CoV-2 antibodies in an average of 10 people for every single known case of COVID-19. More than 120,000 Americans have died from the disease so far.
The governor of Texas temporarily paused the state's reopening on Thursday as COVID-19 infections and hospitalizations in the state continued to increase. Texas recorded 6000 new cases on Monday and has experienced record-breaking hospitalizations for 13 days straight.
Medicine
